Back to top

["Medication, Active": "Beta Blocker Therapy for LVSD"]

Performance/Reporting Period
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent beta blocker therapy for left ventricular systolic dysfunction (LVSD).
Data Element Scope: This value set may use Quality Data Model (QDM) category related to Medication.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; prescribable; bisoprolol, carvedilol, or sustained release metoprolol succinate.
Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.

Constrained to codes in the Medication, Active: Beta Blocker Therapy for LVSD value set (2.16.840.1.113883.3.526.3.1184)

QDM Datatype and Definition (QDM Version 5.4)

"Medication, Active"

Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships.

A QDM Known Issue has been identified related to this datatype. To see this QDM known Issue, please click here.  

Timing: The Relevant Period addresses:

  • startTime - when the medication is first known to be used (generally the time of entry on the medication list),
  • stopTime - when the medication is discontinued (generally, the time discontinuation is recorded on the medication list)
QDM Attributes


Relevant Period addresses the time between the start of an action to the end of an action. Each datatype using relevant period defines specific definitions for the start and stop time for the action listed.
Last Updated: Jul 08, 2021